Results 201 to 210 of about 9,787 (247)

Corrigendum: The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function. [PDF]

open access: yesSci Rep, 2016
Clutton G   +14 more
europepmc   +1 more source

Novel use of alprazolam as a potential HIV-1 latency reversing agent

open access: yesJournal of Virus Eradication, 2017
W. Elbezanti   +4 more
openaire   +2 more sources

Publicly funded private schools and academic achievement: A comparative analysis of PISA data in European countries

open access: yesBritish Educational Research Journal, EarlyView.
Abstract This paper analyses differences in academic achievement associated with attendance at publicly funded private schools and public schools across 11 European countries. Using eight waves of PISA data (2000–2022), we apply OLS, IPW and IPWRA estimators to account for observed heterogeneity and mitigate selection bias.
Priya Maurya   +2 more
wiley   +1 more source

Three novel epigenetic-modifying compounds identified as HIV latency-reversing agents in Ghana

open access: yes
Abana CZ   +13 more
europepmc   +1 more source

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure

open access: yesJournal of Virus Eradication, 2017
Michaela Madlenakova   +6 more
openaire   +2 more sources

Multi‐Scale Hybrid Modeling to Predict Cell Culture Process With Metabolic Phase Transitions

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT To advance understanding of cellular metabolism and reduce batch‐to‐batch variability in cell culture processes, this study introduces a multi‐scale hybrid modeling framework designed to simulate and predict the dynamic behavior of CHO cell cultures undergoing metabolic phase transitions.
Keqi Wang, Sarah W. Harcum, Wei Xie
wiley   +1 more source

New opportunities for bioscaffold‐enabled spinal cord injury repair

open access: yesBMEMat, EarlyView.
Schematic illustration of bioscaffolds for spinal cord injury repair. We summarize the effects of bioscaffold properties on SCI repair, highlight different types of bioscaffolds, various fabrication strategies, and in vivo transformations for the clinical development of SCI‐repairing bioscaffolds.
Xiaoqing Qi   +11 more
wiley   +1 more source

SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo

open access: yesJournal of Virus Eradication, 2017
R.M. Dunham   +4 more
openaire   +2 more sources

Fiber‐type soft bioelectronics for wearable and implantable sensing and therapy

open access: yesBMEMat, EarlyView.
Fiber‐type soft bioelectronics are emerging as versatile platforms for wearable and implantable health monitoring and therapeutic applications. These bioelectronics use organic and inorganic matrices combined with advanced fillers, which feature high conductivity, electrochemical sensitivity, softness, and biocompatibility.
Haneul Kim   +5 more
wiley   +1 more source

Transforming Brain Health With Neurotechnology Convergence (Part II): Intelligent Neurointervention Systems for Neurological Disorders

open access: yesBrain Health, EarlyView.
ABSTRACT Neurological disorders represent a critical domain within global health, necessitating advanced interventions to address complex pathologies such as tumors, functional disorders, and cerebrovascular diseases. Despite the proven benefits of early intervention, current treatment paradigms face significant challenges: (1) limited precision in ...
Qing Ye   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy